Robert DuBridge

Person

Belmont, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Constrained conditionally activated binding proteins
- Patent number 11,744,892
- Issue date Sep 5, 2023
- Takeda Pharmaceutical Company Limited
- Chad May
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Constrained conditionally activated binding proteins
- Patent number 11,744,893
- Issue date Sep 5, 2023
- Takeda Pharmaceutical Company Limited
- Chad May
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single domain antigen binding domains that bind human Trop2
- Patent number 11,685,780
- Issue date Jun 27, 2023
- Takeda Pharmaceutical Company Limited
- Chad May
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single chain variable fragment CD3 binding proteins
- Patent number 11,623,958
- Issue date Apr 11, 2023
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mesothelin binding proteins
- Patent number 11,607,453
- Issue date Mar 21, 2023
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single domain serum albumin binding protein
- Patent number 11,453,716
- Issue date Sep 27, 2022
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Constrained conditionally activated binding proteins
- Patent number 11,406,710
- Issue date Aug 9, 2022
- Takeda Pharmaceutical Company Limited
- Chad May
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of improving characteristics of proteins
- Patent number 11,332,735
- Issue date May 17, 2022
- Full Spectrum Genetics, Inc.
- Robert DuBridge
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Compositions and methods for TCR reprogramming using fusion proteins
- Patent number 11,085,021
- Issue date Aug 10, 2021
- TCR2 THERAPEUTICS INC.
- Patrick Baeuerle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-TNFα binding compounds and uses thereof
- Patent number 10,947,305
- Issue date Mar 16, 2021
- Full Spectrum Genetics, Inc.
- Robert DuBridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-B7H3 binding compounds and uses thereof
- Patent number 10,865,245
- Issue date Dec 15, 2020
- Full Spectrum Genetics, Inc.
- Robert DuBridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prostate specific membrane antigen binding protein
- Patent number 10,849,973
- Issue date Dec 1, 2020
- HARPOON THERAPEUTICS, INC.
- Robert Dubridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PSMA targeting trispecific proteins and methods of use
- Patent number 10,844,134
- Issue date Nov 24, 2020
- HARPOON THERAPEUTICS, INC.
- Patrick Baeuerle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MSLN targeting trispecific proteins and methods of use
- Patent number 10,730,954
- Issue date Aug 4, 2020
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single chain variable fragment CD3 binding proteins
- Patent number 10,544,221
- Issue date Jan 28, 2020
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mesothelin binding proteins
- Patent number 10,543,271
- Issue date Jan 28, 2020
- HARPOON THERAPEUTICS, INC.
- Holger Wesche
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of improving characteristics of proteins
- Patent number 10,526,597
- Issue date Jan 7, 2020
- Full Spectrum Genetics, Inc.
- Robert DuBridge
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Single domain serum albumin binding protein
- Patent number 10,100,106
- Issue date Oct 16, 2018
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single chain variable fragment CD3 binding proteins
- Patent number 10,066,016
- Issue date Sep 4, 2018
- HARPOON THERAPEUTICS, INC.
- Robert B. Dubridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-B7H3 binding compounds and uses thereof
- Patent number 9,963,509
- Issue date May 8, 2018
- Full Spectrum Genetics, Inc.
- Robert DuBridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single domain serum albumin binding protein
- Patent number 9,920,115
- Issue date Mar 20, 2018
- Robert B. Dubridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CTLA4 proteins and their uses
- Patent number 9,587,007
- Issue date Mar 7, 2017
- AbbVie Biotherapeutics Inc.
- Yoshiko Akamatsu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TNF-alpha antibodies and their uses
- Patent number 9,315,573
- Issue date Apr 19, 2016
- AbbVie Biotherapeutics Inc.
- Fiona A. Harding
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-VEGF antibodies and their uses
- Patent number 9,079,953
- Issue date Jul 14, 2015
- AbbVie Biotherapeutics Inc.
- Fiona A. Harding
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-HER2 antibodies and their uses
- Patent number 8,937,159
- Issue date Jan 20, 2015
- AbbVie Biotherapeutics Inc.
- Fiona A. Harding
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CTLA4 proteins and their uses
- Patent number 8,883,971
- Issue date Nov 11, 2014
- AbbVie Biotherapeutics Inc.
- Yoshiko Akamatsu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TNF-α antibodies and their uses
- Patent number 8,722,860
- Issue date May 13, 2014
- AbbVie Biotherapeutics Inc.
- Fiona A. Harding
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-EGFR antibodies and their uses
- Patent number 8,658,175
- Issue date Feb 25, 2014
- AbbVie Biotherapeutics Inc.
- Robert B. Dubridge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CTLA4 proteins and their uses
- Patent number 8,642,557
- Issue date Feb 4, 2014
- AbbVie Biotherapeutics Inc.
- Yoshiko Akamatsu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of screening complex protein libraries to identify altered...
- Patent number 8,633,139
- Issue date Jan 21, 2014
- AbbVie Biotherapeutics Inc.
- Robert DuBridge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC METHODS USING CONSTRAINED CONDITIONALLY ACTIVATED BINDI...
- Publication number 20240199744
- Publication date Jun 20, 2024
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Chad Michael May
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20240199739
- Publication date Jun 20, 2024
- Takeda Pharmaceutical Company Limited
- Chad May
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20240139317
- Publication date May 2, 2024
- Takeda Pharmaceutical Company Limited
- Chad May
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MESOTHELIN BINDING PROTEINS
- Publication number 20240100157
- Publication date Mar 28, 2024
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS
- Publication number 20240084009
- Publication date Mar 14, 2024
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20240026011
- Publication date Jan 25, 2024
- Takeda Pharmaceutical Company Limited
- Robert B. DuBridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20230340159
- Publication date Oct 26, 2023
- Takeda Pharmaceutical Company Limited
- Robert B. DuBridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEIN CONSTRUCTS WITH...
- Publication number 20230312715
- Publication date Oct 5, 2023
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Robert B. DuBridge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN
- Publication number 20230257451
- Publication date Aug 17, 2023
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20220273794
- Publication date Sep 1, 2022
- Takeda Pharmaceutical Company Limited
- Chad MAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20220273795
- Publication date Sep 1, 2022
- Takeda Pharmaceutical Company Limited
- Chad MAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONDITIONALLY ACTIVATED BINDING PROTEINS CONTAINING Fc REGIONS AND...
- Publication number 20220144949
- Publication date May 12, 2022
- TAKEDA PHARMACEUTICAL LIMITED COMPANY
- Robert B. DUBRIDGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COEXPRESSION AND PURIFICATION METHOD OF CONDITIONALLY ACTIVATED BIN...
- Publication number 20210309756
- Publication date Oct 7, 2021
- MAVERICK THERAPEUTICS, INC.
- Robert B. DuBridge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN
- Publication number 20210100902
- Publication date Apr 8, 2021
- Harpoon Therapeutics, Inc.
- Robert DUBRIDGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA Targeting Trispecific Proteins and Methods of Use
- Publication number 20210095047
- Publication date Apr 1, 2021
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20200347132
- Publication date Nov 5, 2020
- MAVERICK THERAPEUTICS, INC.
- Chad MAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MESOTHELIN BINDING PROTEINS
- Publication number 20200289646
- Publication date Sep 17, 2020
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MSLN TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE
- Publication number 20200270362
- Publication date Aug 27, 2020
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS
- Publication number 20200231672
- Publication date Jul 23, 2020
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF IMPROVING CHARACTERISTICS OF PROTEINS
- Publication number 20200123530
- Publication date Apr 23, 2020
- Robert DuBridge
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
NOVEL ANTI-B7H3 BINDING COMPOUNDS AND USES THEREOF
- Publication number 20190338030
- Publication date Nov 7, 2019
- Robert DuBridge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
- Publication number 20190076524
- Publication date Mar 14, 2019
- MAVERICK THERAPEUTICS, INC.
- Chad MAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF IMPROVING CHARACTERISTICS OF PROTEINS
- Publication number 20190078081
- Publication date Mar 14, 2019
- Robert DuBridge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN
- Publication number 20190031749
- Publication date Jan 31, 2019
- Harpoon Therapeutics, Inc.
- Robert B. DUBRIDGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MESOTHELIN BINDING PROTEINS
- Publication number 20180326060
- Publication date Nov 15, 2018
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MSLN TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE
- Publication number 20180327508
- Publication date Nov 15, 2018
- Harpoon Therapeutics, Inc.
- Holger WESCHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA Targeting Trispecific Proteins and Methods of Use
- Publication number 20180162949
- Publication date Jun 14, 2018
- Harpoon Therapeutics, Inc.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Prostate Specific Membrane Antigen Binding Protein
- Publication number 20180161428
- Publication date Jun 14, 2018
- Harpoon Therapeutics, Inc.
- Robert DUBRIDGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCIBLE BINDING PROTEINS AND METHODS OF USE
- Publication number 20180134789
- Publication date May 17, 2018
- MAVERICK THERAPEUTICS, INC.
- Patrick BAEUERLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ANTI-TNFalpha BINDING COMPOUNDS AND USES THEREOF
- Publication number 20180051076
- Publication date Feb 22, 2018
- Robert DuBridge
- C07 - ORGANIC CHEMISTRY

Robert DuBridge

Person

Patents Grantslast 30 patents

Constrained conditionally activated binding proteins

Constrained conditionally activated binding proteins

Single domain antigen binding domains that bind human Trop2

Single chain variable fragment CD3 binding proteins

Mesothelin binding proteins

Single domain serum albumin binding protein

Constrained conditionally activated binding proteins

Method of improving characteristics of proteins

Compositions and methods for TCR reprogramming using fusion proteins

Anti-TNFα binding compounds and uses thereof

Anti-B7H3 binding compounds and uses thereof

Prostate specific membrane antigen binding protein

PSMA targeting trispecific proteins and methods of use

MSLN targeting trispecific proteins and methods of use

Single chain variable fragment CD3 binding proteins

Mesothelin binding proteins

Method of improving characteristics of proteins

Single domain serum albumin binding protein

Single chain variable fragment CD3 binding proteins

Anti-B7H3 binding compounds and uses thereof

Single domain serum albumin binding protein

CTLA4 proteins and their uses

Anti-TNF-alpha antibodies and their uses

Anti-VEGF antibodies and their uses

Anti-HER2 antibodies and their uses

CTLA4 proteins and their uses

Anti-TNF-α antibodies and their uses

Anti-EGFR antibodies and their uses

CTLA4 proteins and their uses

Methods of screening complex protein libraries to identify altered...

Patents Applicationslast 30 patents

THERAPEUTIC METHODS USING CONSTRAINED CONDITIONALLY ACTIVATED BINDI...

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

MESOTHELIN BINDING PROTEINS

SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEIN CONSTRUCTS WITH...

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

CONDITIONALLY ACTIVATED BINDING PROTEINS CONTAINING Fc REGIONS AND...

COEXPRESSION AND PURIFICATION METHOD OF CONDITIONALLY ACTIVATED BIN...

PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN

PSMA Targeting Trispecific Proteins and Methods of Use

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

MESOTHELIN BINDING PROTEINS

MSLN TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE

SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS

METHOD OF IMPROVING CHARACTERISTICS OF PROTEINS

NOVEL ANTI-B7H3 BINDING COMPOUNDS AND USES THEREOF

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

METHOD OF IMPROVING CHARACTERISTICS OF PROTEINS

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

MESOTHELIN BINDING PROTEINS

MSLN TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE

PSMA Targeting Trispecific Proteins and Methods of Use

Prostate Specific Membrane Antigen Binding Protein

INDUCIBLE BINDING PROTEINS AND METHODS OF USE

NOVEL ANTI-TNFalpha BINDING COMPOUNDS AND USES THEREOF